ScholarGate
Assistant

Bleeding Control and Hemostasis

Bleeding control, or surgical hemostasis, is the prevention and arrest of blood loss during an operation. It is achieved by mechanical means such as clamping, ligation, and suture; by thermal and energy-based coagulation; and by topical hemostatic agents and tissue sealants that augment the body's own clotting at the wound surface.

Definition

Surgical hemostasis is the set of intraoperative methods used to prevent and stop bleeding, encompassing mechanical occlusion and ligation, energy-based coagulation, and topical agents or sealants that promote local clot formation.

Scope

This topic covers the categories of intraoperative hemostatic technique - mechanical, thermal/energy-based, and topical - and the principles that govern their selection. It is a reference-educational overview of how bleeding is controlled in the operating room and does not provide protocols, dosing, or individualized management advice.

Core questions

  • How is bleeding prevented during dissection rather than only treated after it occurs?
  • What are the mechanical, thermal, and topical categories of hemostasis and when is each used?
  • How do topical hemostatic agents and sealants differ in how they act?
  • What are the trade-offs between energy-based coagulation and mechanical ligation?

Key concepts

  • Mechanical hemostasis (ligation, clips, sutures)
  • Thermal and energy-based coagulation
  • Topical hemostatic agents
  • Fibrin sealants and tissue glues
  • Augmentation of the coagulation cascade
  • Vessel sealing

Mechanisms

Hemostasis during surgery works at the cut tissue surface and at named vessels. Mechanical methods physically occlude vessels - clamps, ligatures, clips, and sutures - and remain the foundation for larger vessels. Energy-based methods coagulate tissue by heat, sealing small and medium vessels (Wexner, 2011). Topical agents act passively as a scaffold or actively by delivering clotting factors: fibrin sealants combine fibrinogen and thrombin to form a clot at the application site, augmenting the patient's own coagulation (Spotnitz, 2010; Palm & Altman, 2008). The choice among these depends on vessel size, the tissue, and whether bleeding is from a discrete vessel or a diffuse surface.

Clinical relevance

Effective hemostasis limits intraoperative blood loss, improves visibility in the operative field, and reduces the need for transfusion and reoperation for bleeding. This entry describes the categories and mechanisms of hemostatic technique for reference and education; it does not recommend particular agents, devices, or protocols for individual patients, which remain decisions for the surgical team.

Evidence & guidelines

The evidence base includes narrative reviews of topical hemostatic agents and sealants describing their classes and modes of action (Palm & Altman, 2008; Spotnitz, 2010) and experimental comparisons of energy-based vessel sealing devices that quantify sealing strength and thermal spread (Wexner, 2011). Comparative clinical trials of specific agents and devices exist but vary by procedure and are not synthesised here.

History

Surgical control of bleeding by ligature is associated with Ambroise Pare in the sixteenth century and remained the mainstay for centuries. The twentieth century added electrosurgical coagulation, and later decades introduced advanced energy-based vessel-sealing devices and a growing range of topical hemostatic agents and fibrin sealants that augment local clotting (Spotnitz, 2010; Palm & Altman, 2008).

Key figures

  • William D. Spotnitz
  • Melanie D. Palm

Related topics

Seminal works

  • spotnitz-2010
  • palm-2008

Frequently asked questions

What are the main ways surgeons stop bleeding?
They use mechanical methods such as ligation, clips, and sutures; thermal or energy-based coagulation; and topical hemostatic agents or sealants - often in combination, chosen by vessel size and tissue.
How does a fibrin sealant work?
It delivers fibrinogen and thrombin to the bleeding surface, where they combine to form a fibrin clot, augmenting the patient's own coagulation at the site of application.

Methods for this concept

Related concepts